2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit
27-28

May 2020

Germany

Munich

About

We are pleased to invite you to the 2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, scheduled for May 27-28, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development, manufacturing and commercialisation of cell and gene therapies. It is an honour and pr...

We are pleased to invite you to the 2nd Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, scheduled for May 27-28, 2020. This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development. The Summit will shed light on the delivery of cost and quality efficient process development, manufacturing and commercialisation of cell and gene therapies. It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in May!

more info
Who Should Attend

Chief Executives, Vice Presidents, Directors, Heads, Leaders and Managers specialising in:

  • Advanced Therapy Production
  • Analytical
  • Biotherapeutics
  • Cell Engineering
  • Cellular Immunotherapy
  • Clinical Development
  • Gene Therapy
  • GTMPs (Gene Therapy Medicinal Products)
  • Health Economics
  • Immuno-Oncology
  • Immunology Chemistry
  • Legal/IP
  • Market Access
  • Oncology
  • Pricing
  • Quality Control
  • Regenerative Medicine
  • Safety
  • Stem Cell
  • Tissue Therapy
  • ATMP (Advanced Therapy Medicinal Product)
  • Bioprocessing
  • CAR-T
  • Cell Therapy
  • Cellular Therapy
  • CMC
  • GMP
  • CBMPs (Cell-Based Medicinal Products)
  • Immune Deficiencies
  • Immunology
  • Immunotherapy
  • Manufacturing
  • Medical
  • Precision Medicine
  • Process Development
  • R&D
  • Regulatory
  • Sales
  • Supply Chain
Key Practical Learning Points of the Summit

Optimised cell and gene therapies process development, manufacturing, cost and quality efficiency towards successful commercialisation
Emerging science and technologies to enhance cell and gene therapies development
Advanced analytical approaches to improve quality control and real-time release
CMC technical and regulatory compliance to empower cell and gene therapy products development roadmap
Robust supply chain design for precision medicine therapies

Annual

Events

"